Search by Drug Name or NDC
NDC 58552-0336-02 Gilphex 390; 10 mg/1; mg/1 Details
Gilphex 390; 10 mg/1; mg/1
Gilphex is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Gil Pharmaceutical Corp.. The primary component is GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.
Product Information
| NDC | 58552-0336 |
|---|---|
| Product ID | 58552-336_0873c8b3-c1b9-6ef0-e063-6394a90aa7f3 |
| Associated GPIs | |
| GCN Sequence Number | 083887 |
| GCN Sequence Number Description | guaifenesin/phenylephrine HCl TABLET 390MG-10MG ORAL |
| HIC3 | B4W |
| HIC3 Description | DECONGESTANT-EXPECTORANT COMBINATIONS |
| GCN | 52957 |
| HICL Sequence Number | 000250 |
| HICL Sequence Number Description | GUAIFENESIN/PHENYLEPHRINE HCL |
| Brand/Generic | Brand |
| Proprietary Name | Gilphex |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Guaifenesin, Phenylephrine HCl |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 390; 10 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE |
| Labeler Name | Gil Pharmaceutical Corp. |
| Pharmaceutical Class | Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M012 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 58552-0336-02 (58552033602)
| NDC Package Code | 58552-336-02 |
|---|---|
| Billing NDC | 58552033602 |
| Package | 2 TABLET in 1 BLISTER PACK (58552-336-02) |
| Marketing Start Date | 2022-05-05 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |